Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene
- 4 February 2010
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 27 (2) , 157-161
Abstract
Diabet. Med. 27, 157–161 (2010) Aims To investigate all‐cause and cardiovascular mortality in subjects with diabetes caused by a mutation in the hepatocyte nuclear factor 1α gene (HNF1A).Methods We identified 39 British families with HNF1A mutations. Consenting individuals were asked details of age and cause of death of parents and siblings. Copies of death certificates were requested from the family or were obtained via the Offices for National Statistics.Results Data were collated on 241 control subjects and 153 mutation carriers. Of those who died, 66% of mutation carriers died from a cardiovascular‐related illness compared with 43% of control subjects (P = 0.02). Family members with HNF1A mutations died at a younger age than familial control subjects [all‐cause hazard ratio, adjusting for sex and smoking status: 1.9 (95% confidence interval 1.2, 2.9, P = 0.006; cardiovascular hazard ratio: 2.3, confidence interval 1.3, 4.2, P = 0.006)].Conclusions We have shown that individuals known to have diabetes caused by a mutation in the HNF1A gene have an increased risk of cardiovascular mortality compared with their unaffected family members. As with other forms of diabetes, consideration should be given to early statin therapy despite a seemingly protective lipid profile.Keywords
This publication has 19 references indexed in Scilit:
- Hnf1α (MODY3) Controls Tissue-Specific Transcriptional Programs and Exerts Opposed Effects on Cell Growth in Pancreatic Islets and LiverMolecular and Cellular Biology, 2009
- Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studiesJournal of Lipid Research, 2008
- Defining the genetic aetiology of monogenic diabetes can improve treatmentExpert Opinion on Pharmacotherapy, 2006
- Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosisNature Medicine, 2005
- Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β MutationsDiabetes Care, 2004
- Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetesDiabetologia, 2003
- Different genes, different diabetes: lessons from maturity-onset diabetes of the youngAnnals of Medicine, 2002
- Different genes, different diabetes: lessons from maturity-onset diabetes of the youngAnnals of Medicine, 2002
- The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitusDiabetic Medicine, 1999
- Chronic diabetic complications in patients with MODY3 diabetesDiabetologia, 1998